MRGPRX2 and progressive osseous heteroplasia: MRGPRX2 mutations recently reported in a patient with POH to rocuronium displayed loss-of-function phenotype, thus disputing the role of MRGPRX2 in rocuronium-induced POH and suggesting that the mechanism of rocuronium-induced POH is more complex than previously thought.